Frontiers in Oncology | Hematologic Malignancies

Mini Review

Published on 08 Aug 2024

Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma

in Hematologic Malignancies

Issam S. Hamadeh
Reed Friend
Sham Mailankody
Shebli Atrash

Frontiers in Oncology

doi 10.3389/fonc.2024.1455464

4,603 views
3 citations

Original Research

Published on 07 Aug 2024

Exploring the educational needs of patients with cutaneous lymphoma using an educational needs assessment tool

in Hematologic Malignancies

Lina U. Ivert
Anna H. Winther
Pontus Jonsson
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2024.1433821

1,332 views

Case Report

Published on 05 Aug 2024

Insights into uveitis from Brentuximab vedotin in refractory Hodgkin’s lymphoma: a case report and brief review

in Hematologic Malignancies

Mengyuan Liu
Kexing Ren
Ping Ai
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2024.1419145

1,557 views
2 citations

Review

Published on 02 Aug 2024

MicroRNA dysregulation in myelodysplastic syndromes: implications for diagnosis, prognosis, and therapeutic response

in Hematologic Malignancies

Ilina Dimitrova Micheva
Svilena Angelova Atanasova

Frontiers in Oncology

doi 10.3389/fonc.2024.1410656

1,894 views

Case Report

Published on 01 Aug 2024

Case report: DKRd regimen in the treatment of newly diagnosed POEMS syndrome and literature review

in Hematologic Malignancies

Jianchao Wang
Wensheng Liao
Zhongwen Liu
Dai Kong

Frontiers in Oncology

doi 10.3389/fonc.2024.1417380

1,804 views

Case Report

Published on 31 Jul 2024

Case report: An intriguing case of Philadelphia chromosome–positive acute lymphoblastic leukemia recurrence

in Hematologic Malignancies

Nicolò Peccatori
Elena Chiocca
Valentino Conter
Annalisa Tondo
Matilde Marzorati
Tommaso Casini
Marinella Veltroni
Andrea Biondi
Grazia Fazio

Frontiers in Oncology

doi 10.3389/fonc.2024.1457832

1,755 views

Systematic Review

Published on 31 Jul 2024

Challenges in overcoming advanced-stage or relapsed refractory extranodal NK/T-cell lymphoma: meta-analysis of individual patient data

in Hematologic Malignancies

Tong Yoon Kim
Tae Jung Kim
Eun Ji Han
Gi June Min
Youngwoo Jeon
Seok-Goo Cho

Frontiers in Oncology

doi 10.3389/fonc.2024.1362367

1,592 views

Systematic Review

Published on 31 Jul 2024

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

Si Yu Lin
Ke Jie Lu
Xiao Na Zheng
Jian Hou
Ting Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1341631

1,718 views
1 citation

Review

Published on 29 Jul 2024

Therapeutic options for chronic myeloid leukemia following the failure of second-generation tyrosine kinase inhibitor therapy

in Hematologic Malignancies

Binsah George
Kok Hoe Chan
Adan Rios

Frontiers in Oncology

doi 10.3389/fonc.2024.1446517

2,911 views
1 citation

Review

Published on 29 Jul 2024

Novel insights and therapeutic approaches in secondary AML

in Hematologic Malignancies

Giovanni Marconi
Michela Rondoni
Beatrice Anna Zannetti
Irene Zacheo
Davide Nappi
Agnese Mattei
Serena Rocchi
Francesco Lanza

Frontiers in Oncology

doi 10.3389/fonc.2024.1400461

3,877 views
4 citations

Original Research

Published on 29 Jul 2024

Tumor-informed ctDNA assessment as a valuable prognostic and predictive biomarker in diffuse large B-cell lymphoma

in Hematologic Malignancies

Mayur Narkhede
Sarah Tomassetti
Madiha Iqbal
Antony Tin
Samuel Rivero-Hinojosa
Giby V. George
Hayley Widden
Ryan Benrud
Meenakshi Malhotra
Angel Rodriguez

Frontiers in Oncology

doi 10.3389/fonc.2024.1407003

3,273 views

Review

Published on 26 Jul 2024

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms

in Hematologic Malignancies

Luca L. G. Janssen
Nathalie van Leeuwen-Kerkhoff
Theresia M. Westers
Tanja D. de Gruijl
Arjan A. van de Loosdrecht

Frontiers in Oncology

doi 10.3389/fonc.2024.1414102

2,975 views

Review

Published on 24 Jul 2024

Epidemiology and disease characteristics of myelofibrosis: a comparative analysis between Italy and global perspectives

in Hematologic Malignancies

Massimo Breccia
Francesca Palandri
Nicola Polverelli
Morena Caira
Michela Berluti
Giuseppe A. Palumbo
Valerio De Stefano

Frontiers in Oncology

doi 10.3389/fonc.2024.1382872

6,152 views
1 citation

Original Research

Published on 19 Jul 2024

Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia

in Hematologic Malignancies

Xiaohong Wang
Jason Ostergaard
Jongseok Kang
Grace Sagong
Rachel Twite
Andrea Vargas-Morales
Peter M. Gordon

Frontiers in Oncology

doi 10.3389/fonc.2024.1440650

1,757 views

Review

Published on 19 Jul 2024

Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma

in Hematologic Malignancies

Fernando J. Medina-Olivares
Andrés Gómez-De León
Nilanjan Ghosh

Frontiers in Oncology

doi 10.3389/fonc.2024.1397613

4,816 views
6 citations

Mini Review

Published on 18 Jul 2024

Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas

in Hematologic Malignancies

Domenico Ribatti
Gerardo Cazzato
Roberto Tamma
Tiziana Annese
Giuseppe Ingravallo
Giorgina Specchia

Frontiers in Oncology

doi 10.3389/fonc.2024.1420920

2,806 views
5 citations